Kamal Mostafa 4
4 · MAGELLAN HEALTH INC · Filed Dec 11, 2020
Insider Transaction Report
Form 4
Kamal Mostafa
CEO, Magellan Rx Management
Transactions
- Sale
Ordinary Common Stock, $0.01 par value
2020-12-09$79.69/sh−2,793$222,574→ 2,824 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b-5-1 Plan.